(Q33330423)

English

Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Kasabach-Merritt syndrome

1 reference

based on heuristic

inferred from title

author name string

Verheul HM

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Panigrahy D

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Flynn E

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Pinedo HM

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D'Amato RJ

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Pediatric Research

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

562-565

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

https://scigraph.springernature.com/pub.10.1203/00006450-199911000-00012

0 references

Kasabach-Merritt syndrome

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-Merritt syndrome).

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURA

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199911000-00012

21 January 2018

Identifiers

10.1203/00006450-199911000-00012

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33330423&oldid=1956681259"